Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
active epistaxis: initial measures
clear nose and apply pressure ± vasoconstrictor
Advise the patient to clear their nose of blood because blood clot may promote fibrinolysis.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com They should hold their head in a "sniffing" position, flexed slightly forward.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Then apply firm and sustained pressure to the lower third of the nose (the entire lower compressible cartilage) with or without assistance from a parent or caregiver for at least 5 minutes.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com A nose clip can be used if available and tolerated by the patient.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Consider applying topical vasoconstrictor (decongestant), such as oxymetazoline, using a nasal spray or by inserting impregnated cotton balls or pledgets before the actual evaluation begins into the nose.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Apply the vasoconstrictor for both diagnostic and therapeutic purposes, to help visualize the epistaxis site and encourage hemostasis. A decongestant will also shrink mucosal thickness, allowing more open nasal space should placement of a pack be required. This can reduce mucosal trauma incurred during insertion of a pack and thereby decrease secondary bleeding sites from disrupted mucus membrane.
resuscitation and supportive measures
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Initial assessment may reveal an obvious underlying cause or exacerbating factor.
Underlying causes, such as septal deviation or perforation, may become apparent.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Treat local causes such as foreign body, polyp, and ulceration to the skin around the nose accordingly.[27]Randall DA. Epistaxis packing. Practical pointers for nosebleed control. Postgrad Med. 2006 Jun-Jul;119(1):77-82. http://www.ncbi.nlm.nih.gov/pubmed/16913650?tool=bestpractice.com
Coagulation disorders may require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Provide a post-treatment nosebleed instruction sheet.
active epistaxis: persistent bleeding precluding identification of bleeding site
anterior nasal packing
If you cannot identify the exact site of the bleeding, treat active bleeding that is not controlled by nasal pressure with nasal packing.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com [23]Bequignon E, Vérillaud B, Robard L, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 May;134(3):185-9. https://www.sciencedirect.com/science/article/pii/S1879729616301661?via%3Dihub http://www.ncbi.nlm.nih.gov/pubmed/27789155?tool=bestpractice.com With adequate resources, you can perform anterior nasal packing in outpatient offices or emergency departments.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
In most cases, use nonresorbable packing. There are 2 types of packing method, traditional packing and a variety of gauze dressings, polymers, and inflatable balloons available in different sizes.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Traditional packing involves horizontal layering of 12-mm (half-inch) cotton gauze saturated with petroleum jelly or antibiotic ointment.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The newer options are more convenient and easier to position than traditional packing, particularly for physicians who infrequently place nasal packing. Because of concerns that packing material may become displaced, some patients are managed in the hospital, but uncomplicated patients with nosebleeds controlled with nonresorbable anterior packing can usually be managed as outpatients, depending on local protocols.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com [30]Upile T, Jerjes W, Sipaul F, et al. A change in UK epistaxis management. Eur Arch Otorhinolaryngol. 2008 Nov;265(11):1349-54. http://www.ncbi.nlm.nih.gov/pubmed/18392840?tool=bestpractice.com Remove all types of nonresorbable packings at some point after achieving sustained control of nasal hemorrhage.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The pack is usually removed at 48-72 hours.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com This allows: 1) healing of the original bleeding site; 2) remucosalization of any secondary sites from pack insertion trauma; 3) regeneration of functional platelets or clotting factors in patients on medications that impair coagulation.
As epistaxis generally originates on one side, packing is unilateral. Bilateral packing is only indicated in the unusual situation of true hemorrhage from both sides, or when the history and examination fail to identify whether the bleeding is from the right or the left. In practice, nonspecialists often resort to bilateral packing as it is difficult to determine accurately the true site of the bleed.
Demonstrates insertion of an inflatable anterior nasal pack and a nasal tampon.
Use resorbable packing (that does not need to be removed) for a patient with a suspected bleeding disorder, on antiplatelet or anticoagulant medication; vascular abnormalities such as hereditary hemorrhagic telangiectasia; or for a young child.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
A variety of resorbable materials is available, including oxidized regenerated cellulose, synthetic polyurethane sponge, chitosan-based materials, purified porcine skin and gelatin granules and hemostatic gelatin thrombin matrices, carboxymethylcellulose gel, hyaluronic acid, and carboxymethylcellulose.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Choose the specific packing based on local availability and experience; there is limited comparative evidence to support the use of one material over any other.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Although controversial, consider oral antibiotics on an individual basis while resorbable and nonresorbable packing remains in place, because impaired sinus drainage and aeration increases risk of infection.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The blood saturated pack can (though rarely does) result in toxic shock syndrome.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Antimicrobials have potential for benefit with minimal risk.
Select antibiotics that have activity against typical sinusitis pathogens and Staphylococcus aureus.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Appropriate antibiotics include trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, or cefuroxime. Use a macrolide or fluoroquinolone in the case of allergy to penicillin or cephalosporins.
Although there is little evidence of protective benefit from toxic shock syndrome by application of topical antibiotic ointment, its use to lubricate packing and reduce trauma is reasonable and commonplace.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Primary options
sulfamethoxazole/trimethoprim: 160 mg orally twice daily for 5-7 days
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
or
amoxicillin/clavulanate: 500 mg orally twice daily for 5-7 days
More amoxicillin/clavulanateDose refers to amoxicillin component.
or
cefuroxime axetil: 250-500 mg orally twice daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
Secondary options
clarithromycin: 500 mg orally twice daily for 4-7 days
or
azithromycin: 500 mg orally once daily on day 1, followed by 250 mg once daily for 4 days
or
levofloxacin: 500 mg orally once daily for 5-7 days
or
moxifloxacin: 400 mg orally once daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
analgesia
Treatment recommended for SOME patients in selected patient group
Prescribe analgesia, as appropriate, for discomfort. A combination of acetaminophen/hydrocodone, or similar, is recommended. Avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs).
Primary options
hydrocodone/acetaminophen: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
More hydrocodone/acetaminophenDose refers to acetaminophen component.
antiemetic
Treatment recommended for SOME patients in selected patient group
Give ondansetron for nausea that may be caused by swallowed blood.
Primary options
ondansetron: 4-8 mg intravenously every 8 hours when required
resuscitation and supportive measures
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Coagulation disorders require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Local underlying factors may not be visible due to the volume of blood.
Provide a post-treatment nosebleed instruction sheet.
active epistaxis: bleeding site visible
clear nose ± vasoconstrictor/anesthetic ± cautery
Remove any blood clot (if present) because blood clot may promote fibrinolysis.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Perform anterior rhinoscopy with a nasal speculum (or otoscope, particularly in children) to identify any bleeding source on the anterior nasal septum, inferior and middle turbinates, floor of the nose, and anterior nasal mucosa.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Consider applying a combination of topical anesthetic (e.g., lidocaine) and vasoconstrictor (decongestant) at this stage.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Topical anesthetic makes the procedure more comfortable for the patient and less stressful for the physician. Some physicians prepare a mixture of anesthetic and decongestant in the office or emergency department. For the decongestant, use oxymetazoline rather than phenylephrine as the latter seems more likely to cause hypertension or possibly angina in susceptible patients. Some physicians simply remove the top from a spray bottle of oxymetazoline, add an equal volume of the lidocaine, and replace the top; however, seek specialist advice.
Active bleeding may necessitate rapid alternation between clearing of blood and liberal application of the topical vasoconstrictor and anesthetic.
Next, place small neurosurgical pledgets or strips of cotton well saturated with the mixture horizontally in the nose with bayonet forceps, and leave for 10 to 15 minutes. Ask the patient to compress their nose if necessary. [Figure caption and citation for the preceding image starts]: Nasal pledgets for application of decongestant and local anestheticFrom the collection of David A. Randall, Springfield Ear Nose Throat and Facial Plastic Surgery, MO [Citation ends].
Treat patients with an identified bleeding site with one or more of the following options, as appropriate: topical vasoconstrictors (including oxymetazoline, phenylephrine, epinephrine, or cocaine), nasal cautery, and moisturizing or lubricating agents.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Moisturizing and lubricating agents would not usually be used for an active bleed, but would most commonly be applied after cessation of bleeding following cautery and/or vasoconstrictors.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Combinations of several methods are often used; with little evidence comparing options, the American Academy of Otolaryngology guideline refrains from recommending a specific order for these interventions.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
The American Academy of Otolaryngology guideline recognizes that the British Rhinological Society recommends that vasoconstrictors should be used prior to cautery, and that cautery of an identified bleeding site should be first-line treatment; however, the US guideline notes that these recommendations were based on limited evidence.[28]National ENT Trainee Research Network. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis. J Laryngol Otol. 2017 Dec;131(12):1142-56. http://www.ncbi.nlm.nih.gov/pubmed/29280691?tool=bestpractice.com Give oxymetazoline or phenylephrine as an intranasal spray or on a cotton pledget, but be cautious in patients with hypertension, cardiac disease, or cerebrovascular conditions, as vasoconstrictors may be associated with cardiac and other complications.
The American Academy of Otolaryngology guideline does not specify a preference for either the chemical or electrical method of cautery.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Silver nitrate, chromic acid, or trichloroacetic acid can be used for chemical cautery.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com However, electrocautery is suggested to be more effective than chemical cautery if the relevant resources and expertise are available.[28]National ENT Trainee Research Network. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis. J Laryngol Otol. 2017 Dec;131(12):1142-56. http://www.ncbi.nlm.nih.gov/pubmed/29280691?tool=bestpractice.com
Perform electrocautery for brisker bleeding that is resistant to silver nitrate treatment. This procedure is usually reserved for the ear, nose, and throat (ENT) specialist. It requires injection of local anesthetic plus vasoconstrictor (e.g., lidocaine with epinephrine), in addition to topical anesthetic. Monopolar and bipolar cautery are both effective. Suction monopolar cautery (if available) evacuates blood and enhances effect, as cautery is ineffective in a wet, blood-filled field. Provide routine post-treatment instructions.
Although most frequently used for office treatment of recurrent epistaxis when bleeding is quiescent, use silver nitrate cautery to treat minor anterior active epistaxis if you have identified a specific site.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Silver nitrate is applied via commercially manufactured sticks or applicators. This compound degrades over time and must be kept in an airtight, lightproof container. Lack of evident activity may indicate the need to use fresher silver nitrate.
The technique for anterior nasal cautery is suggested as follows:
1) Anesthetize the bleeding site adequately; recommendations do not specify a preference for topical or injected anesthetic agents.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Lidocaine or tetracaine are common options.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Lidocaine can be injected into the nasal septum or administered topically via spray or on pledgets.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
2) Apply the cauterizing agent to specific vessels or hemorrhagic areas of concern, and remove excess with a cotton tip applicator.
3) The patient may find treatment uncomfortable even with adequate application of topical vasoconstrictor and anesthetic.
4) Apply petroleum jelly afterward for moisturization.
5) Avoid cautery at the same location on both sides of the septum. This deprives the septal cartilage of its blood supply (from the mucosal covering) and may result in septal perforation if done bilaterally.
6) Provide routine post-treatment instructions.[1]Tan L, Calhoun K. Epistaxis. Med Clin North Am. 1999 Jan;83(1):43-56. http://www.ncbi.nlm.nih.gov/pubmed/9927959?tool=bestpractice.com [2]Perretta L, Denslow B, Brown C. Emergency evaluation and management of epistaxis. Emerg Med Clin North Am. 1987 May;5(2):265-77. http://www.ncbi.nlm.nih.gov/pubmed/3436294?tool=bestpractice.com [29]Barr G. Silver nitrate cautery and epistaxis. Arch Emerg Med. 1989 Sep;6(3):233. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1285615&blobtype=pdf http://www.ncbi.nlm.nih.gov/pubmed/2789592?tool=bestpractice.com
resuscitation and supportive care
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Underlying causes, such as septal deviation or perforation, may become apparent.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Treat local causes such as foreign body, polyp, and ulceration to the skin around the nose accordingly.[27]Randall DA. Epistaxis packing. Practical pointers for nosebleed control. Postgrad Med. 2006 Jun-Jul;119(1):77-82. http://www.ncbi.nlm.nih.gov/pubmed/16913650?tool=bestpractice.com
Initial assessment may reveal an obvious underlying cause or exacerbating factor, such as coagulopathy.
Coagulation disorders may require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Provide a post-treatment nosebleed instruction sheet.
unilateral or bilateral anterior packing
Use anterior nasal packing for active bleeding when cautery has been ineffective. There are 2 types of packing method, traditional packing and a variety of gauze dressings, polymers, and inflatable balloons available in different sizes.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Traditional packing involves horizontal layering of 12-mm (half-inch) cotton gauze saturated with petroleum jelly or antibiotic ointment.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The newer options are more convenient and easier to position than traditional packing, particularly for physicians who infrequently place nasal packing. Because of concerns that packing material may become displaced, some patients are managed in the hospital, but uncomplicated patients with nosebleeds controlled with nonresorbable anterior packing can usually be managed as outpatients, depending on local protocols.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com [30]Upile T, Jerjes W, Sipaul F, et al. A change in UK epistaxis management. Eur Arch Otorhinolaryngol. 2008 Nov;265(11):1349-54. http://www.ncbi.nlm.nih.gov/pubmed/18392840?tool=bestpractice.com Remove all types of nonresorbable packings at some point after achieving sustained control of nasal hemorrhage.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The pack is usually removed at 48-72 hours.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com This allows: 1) healing of the original bleeding site; 2) remucosalization of any secondary sites from pack insertion trauma; 3) regeneration of functional platelets or clotting factors in patients on medications that impair coagulation.
As epistaxis generally originates on one side, packing is unilateral. Bilateral packing is only indicated in the unusual situation of true hemorrhage from both sides, or when the history and examination fail to identify whether the bleeding is from the right or the left. In practice, nonspecialists often resort to bilateral packing as it is difficult to determine accurately the true site of the bleed.
Demonstrates insertion of an inflatable anterior nasal pack and a nasal tampon.
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Although controversial, consider oral antibiotics on an individual basis while resorbable and nonresorbable packing remains in place, because impaired sinus drainage and aeration increases risk of infection.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The blood saturated pack can (though rarely does) result in toxic shock syndrome.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Antimicrobials have potential for benefit with minimal risk.
Select antibiotics that have activity against typical sinusitis pathogens and Staphylococcus aureus.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Appropriate antibiotics include trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, or cefuroxime. Use a macrolide or fluoroquinolone in the case of allergy to penicillin or cephalosporins.
Although there is little evidence of protective benefit from toxic shock syndrome by application of topical antibiotic ointment, its use to lubricate packing and reduce trauma is reasonable and commonplace.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Primary options
sulfamethoxazole/trimethoprim: 160 mg orally twice daily for 5-7 days
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
or
amoxicillin/clavulanate: 500 mg orally twice daily for 5-7 days
More amoxicillin/clavulanateDose refers to amoxicillin component.
or
cefuroxime axetil: 250-500 mg orally twice daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
Secondary options
clarithromycin: 500 mg orally twice daily for 4-7 days
or
azithromycin: 500 mg orally once daily on day 1, followed by 250 mg once daily for 4 days
or
levofloxacin: 500 mg orally once daily for 5-7 days
or
moxifloxacin: 400 mg orally once daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
analgesia
Treatment recommended for SOME patients in selected patient group
Prescribe analgesia, as appropriate, for discomfort. A combination of acetaminophen/hydrocodone, or similar, is recommended. Avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs).
Primary options
hydrocodone/acetaminophen: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
More hydrocodone/acetaminophenDose refers to acetaminophen component.
antiemetic
Treatment recommended for SOME patients in selected patient group
Give ondansetron for nausea that may be caused by swallowed blood.
Primary options
ondansetron: 4-8 mg intravenously every 8 hours when required
resuscitation and supportive care
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Underlying causes may become apparent at this stage.
Coagulation disorders require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Treat local causes (e.g., foreign body, polyp, ulceration to the skin around the nose) accordingly.
Provide a post-treatment nosebleed instruction sheet.
posterior packing
Perform posterior packing in an emergency department or hospital setting. Care of patients requiring this level of packing should involve an otolaryngology attending.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Anterior-posterior nasal packing is indicated: 1) for known posterior bleeding; 2) in case of failure of a properly placed anterior pack to control hemorrhage.
Use anterior packing to reinforce posterior packing; the pressure at the posterior choanal area prevents anterior blood flow.
A variety of posterior pack options exist, although the methods described below provide both effectiveness and ease of placement. These are: 1) the double-balloon epistaxis device; 2) the traditional gauze anterior pack with the Foley urinary catheter placed posteriorly.
See the Management Approach section of this topic for details of how to place these packs.
[Figure caption and citation for the preceding image starts]: Anterior-posterior traditional Foley catheter-gauze packFrom the collection of David A. Randall, Springfield Ear Nose Throat and Facial Plastic Surgery, MO [Citation ends].
There has been concern about posterior packs causing hypoxia, and the need for intensive cardiorespiratory monitoring while the packs remain in place.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Some authors recommend observation of patients in the intensive care unit while posterior packing is in place, while others feel that this is appropriate specifically for older people and patients with comorbidities.
Remove packing after 2 to 3 days to allow healing of the original and possibly secondary (from excoriation of packing placement) bleeding sites.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Although controversial, consider oral antibiotics on an individual basis while resorbable and nonresorbable packing remains in place, because impaired sinus drainage and aeration increases risk of infection.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com The blood saturated pack can (though rarely does) result in toxic shock syndrome.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Antimicrobials have potential for benefit with minimal risk.
Select antibiotics that have activity against typical sinusitis pathogens and Staphylococcus aureus.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Appropriate antibiotics include trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, or cefuroxime. Use a macrolide or fluoroquinolone in the case of allergy to penicillin or cephalosporins.
Although there is little evidence of protective benefit from toxic shock syndrome by application of topical antibiotic ointment, its use to lubricate packing and reduce trauma is reasonable and commonplace.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Primary options
sulfamethoxazole/trimethoprim: 160 mg orally twice daily for 5-7 days
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
or
amoxicillin/clavulanate: 500 mg orally twice daily for 5-7 days
More amoxicillin/clavulanateDose refers to amoxicillin component.
or
cefuroxime axetil: 250-500 mg orally twice daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
Secondary options
clarithromycin: 500 mg orally twice daily for 4-7 days
or
azithromycin: 500 mg orally once daily on day 1, followed by 250 mg once daily for 4 days
or
levofloxacin: 500 mg orally once daily for 5-7 days
or
moxifloxacin: 400 mg orally once daily for 5-7 days
-- AND --
mupirocin topical: (2% ointment) to generously saturate nasal packing before placement
analgesia
Treatment recommended for SOME patients in selected patient group
Prescribe analgesia, as appropriate, for discomfort. A combination of acetaminophen/hydrocodone, or similar, is recommended.
Greater patient discomfort with posterior nasal packing warrants consideration of an intravenous opioid analgesic prior to packing.
Use opioids with caution in older and shocked patients.
Lidocaine with epinephrine may be infiltrated in the vicinity of a bleeding site. There is hemostatic benefit from the epinephrine and possibly from hydrostatic tissue pressure of the infiltrated volume of medication. This method is a requirement before electrocautery is undertaken but may be used with other treatments.
Posterior analgesia and vasoconstriction may be facilitated by local anesthetic infiltration into the greater palatine foramen. This block technique should be used with caution and only in experienced hands because it is painful and has the rare potential for blindness. This is rarely used.
Avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs).
Primary options
hydrocodone/acetaminophen: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
More hydrocodone/acetaminophenDose refers to acetaminophen component.
OR
morphine sulfate: 2-10 mg intravenously every 3-4 hours when required, titrate according to response
antiemetic
Treatment recommended for SOME patients in selected patient group
Greater patient discomfort with posterior nasal packing warrants consideration of an antiemetic prior to packing. Pretreatment with an antiemetic avoids nausea and emesis. Ondansetron avoids sedation associated with medications such as promethazine.
Primary options
ondansetron: 4-8 mg intravenously every 8 hours when required
resuscitation and supportive care
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Coagulation disorders require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Treat local causes (e.g., neoplasm, foreign body, polyp, ulceration to the skin around the nose) accordingly.
Provide a post-treatment nosebleed instruction sheet.
endoscopic management or angiography and embolization
Nasal packing and cautery will successfully treat most nosebleeds. Otolaryngology referral is indicated when these techniques fail. Various procedures may be used to manage persistent bleeding. The choice will depend on availability of appropriate resources and expertise.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com [31]Morganstein S. Surgical management of epistaxis. Arch Otolaryngol Head Neck Surg. 1987 Dec;113(12):1338. http://www.ncbi.nlm.nih.gov/pubmed/3675902?tool=bestpractice.com [32]Moshaver A, Harris JR, Liu R, et al. Early operative intervention versus conventional treatment in epistaxis: randomized prospective trial. J Otolaryngol. 2004 Jun;33(3):185-8. http://www.ncbi.nlm.nih.gov/pubmed/15841998?tool=bestpractice.com [33]Durr DG. Endoscopic electrosurgical management of posterior epistaxis: shifting paradigm. J Otolaryngol. 2004 Aug;33(4):211-6. http://www.ncbi.nlm.nih.gov/pubmed/15903200?tool=bestpractice.com [34]Stankiewicz J. Nasal endoscopy and control of epistaxis. Curr Opin Otolaryngol Head Neck Surg. 2004 Feb;12(1):43-5. http://www.ncbi.nlm.nih.gov/pubmed/14712120?tool=bestpractice.com [35]Kumar S, Shetty A, Rockey J, et al. Contemporary surgical treatment of epistaxis: what is the evidence for sphenopalatine artery ligation? Clin Otolaryngol Allied Sci. 2003 Aug;28(4):360-3. http://www.ncbi.nlm.nih.gov/pubmed/12871253?tool=bestpractice.com [36]Strong E, Bell D, Johnson L, et al. Intractable epistaxis: transantral ligation vs embolization: efficacy review and cost analysis. Otolaryngol Head Neck Surg. 1995 Dec;113(6):674-8. http://www.ncbi.nlm.nih.gov/pubmed/7501376?tool=bestpractice.com [37]Christensen N, Smith D, Barnwell S, et al. Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg. 2005 Nov;133(5):748-53. http://www.ncbi.nlm.nih.gov/pubmed/16274804?tool=bestpractice.com
The advent of rigid nasal endoscopy has greatly improved visualization and access to the nose. Endoscopic identification and guided electrocautery to posterior bleeding sites have become more common and an effective alternative to nasal packing.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Suction cautery under direct visualization may control some nosebleeds located posteriorly. Similarly, surgical dissection and surgical clip ligation of the sphenopalatine artery (SPA) may be accomplished under direct endoscopic vision.[33]Durr DG. Endoscopic electrosurgical management of posterior epistaxis: shifting paradigm. J Otolaryngol. 2004 Aug;33(4):211-6. http://www.ncbi.nlm.nih.gov/pubmed/15903200?tool=bestpractice.com [34]Stankiewicz J. Nasal endoscopy and control of epistaxis. Curr Opin Otolaryngol Head Neck Surg. 2004 Feb;12(1):43-5. http://www.ncbi.nlm.nih.gov/pubmed/14712120?tool=bestpractice.com SPA ligation is the mainstay of treatment when conservative management of posterior epistaxis has failed.[39]Douglas R, Wormald PJ. Update on epistaxis. Curr Opin Otolaryngol Head Neck Surg. 2007 Jun;15(3):180-3. http://www.ncbi.nlm.nih.gov/pubmed/17483687?tool=bestpractice.com It is usually performed under a general anesthetic but can be accomplished under sedation with local anesthetic.
This procedure offers another means of interrupting the arterial supply, avoiding the need for surgery. If contemplating this technique, try it before transantral ligation because the latter often occludes access vessels necessary for successful embolization.[36]Strong E, Bell D, Johnson L, et al. Intractable epistaxis: transantral ligation vs embolization: efficacy review and cost analysis. Otolaryngol Head Neck Surg. 1995 Dec;113(6):674-8. http://www.ncbi.nlm.nih.gov/pubmed/7501376?tool=bestpractice.com [37]Christensen N, Smith D, Barnwell S, et al. Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg. 2005 Nov;133(5):748-53. http://www.ncbi.nlm.nih.gov/pubmed/16274804?tool=bestpractice.com [40]Scaramuzzi N, Walsh R, Brennan P, et al. Treatment of intractable epistaxis using arterial embolization. Clin Otolaryngol Allied Sci. 2001 Aug;26(4):307-9. http://www.ncbi.nlm.nih.gov/pubmed/11559343?tool=bestpractice.com
Endovascular embolization is appropriate for treating posterior epistaxis and involves embolization of the bilateral sphenopalatine/distal internal maxillary arteries. Sometimes, the facial arteries require embolization if there are anastomoses with the SPA via the infraorbital artery and alar and septal branches from the anterior nasal compartment.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
An advantage of endoscopic arterial ligation is that concurrent endoscopic SPA and endoscopic anterior ethmoidal artery ligation can be performed; however, the need for general anesthesia is a disadvantage.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Advantages of embolization include the ability to perform the procedure under sedation, avoid trauma to the nasal mucosa, and leave packs in place, but there is some risk of occlusion of adjacent vessels and the potential for cerebrovascular accident.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com A sequential approach of transnasal endoscopic SPA ligation (TESPAL) followed by endovascular embolization for epistaxis that does not respond to packing has been suggested.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com [38]Leung RM, Smith TL, Rudmik L. Developing a laddered algorithm for the management of intractable epistaxis: a risk analysis. JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):405-9. https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2167109 http://www.ncbi.nlm.nih.gov/pubmed/25719360?tool=bestpractice.com
Obtain detailed prior angiography (including internal and external carotid arteries) because blindness and stroke are serious complications that, although rare, occur more frequently than in patients undergoing surgical arterial ligation. Endovascular embolization of the anterior and/or posterior ethmoid arteries is contraindicated, because of the risk of blindness.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
analgesia
Treatment recommended for SOME patients in selected patient group
Prescribe analgesia, as appropriate, for discomfort. A combination of acetaminophen/hydrocodone, or similar, is recommended. Avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs).
Primary options
hydrocodone/acetaminophen: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
More hydrocodone/acetaminophenDose refers to acetaminophen component.
antiemetic
Treatment recommended for SOME patients in selected patient group
The anesthetist may prescribe ondansetron as needed for nausea postoperatively.
Primary options
ondansetron: 4-8 mg intravenously every 8 hours when required
resuscitation and supportive care
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Coagulation disorders require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Treat local causes (e.g., foreign body, polyp, ulceration to the skin around the nose) accordingly.
Provide a post-treatment nosebleed instruction sheet.
open surgical ligation
Posterior epistaxis may be amenable to endoscopically guided electrocautery (usually monopolar suction cautery). Similarly, surgical dissection and surgical clip ligation of the sphenopalatine artery may be accomplished under direct endoscopic vision. These procedures normally require general anesthetic or at least conscious sedation in the operating room. Packing is therefore the more amenable primary option.
Angiography and embolization offers another means of interrupting the arterial supply. This avoids the need for surgery but involves some risk of occlusion of adjacent vessels and the potential for cerebrovascular accident. If contemplated, this technique should be tried before transantral ligation because this surgery often occludes access vessels necessary for successful embolization.
analgesia
Treatment recommended for SOME patients in selected patient group
Prescribe analgesia, as appropriate, for discomfort. A combination of acetaminophen/hydrocodone, or similar, is recommended. Avoid aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs).
Primary options
hydrocodone/acetaminophen: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
More hydrocodone/acetaminophenDose refers to acetaminophen component.
antiemetic
Treatment recommended for SOME patients in selected patient group
The anesthetist may prescribe ondansetron as needed for nausea postoperatively.
Primary options
ondansetron: 4-8 mg intravenously every 8 hours when required
resuscitation and supportive care
Treatment recommended for SOME patients in selected patient group
Prompt assessment of bleeding severity will assist in directing the patient to the proper clinical site for management. Few studies address the most appropriate setting for care of nosebleeds.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Generally, resuscitation is not required in most people presenting with epistaxis, but is required in the rare instance of hemodynamic compromise. Such patients need urgent resuscitation in the hospital.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com Patients may be more prone to hemodynamic compromise if: 1) there is severe bleeding, indicated by a large volume of blood, prolonged bleeding, bleeding from both sides of the nose, or bleeding from the mouth. Severe bleeding may be more likely with a history of hospitalization for nosebleed, prior blood transfusion for nosebleed, or more than 3 recent nosebleeds; 2) the patient is older; or 3) the patient is ill or frail. Comorbidities that may impede the patient's response to a bleed include hypertension, cardiopulmonary disease, anemia, bleeding disorders, and liver or kidney disease.[8]Tunkel DE, Anne S, Payne SC, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1 suppl):S1-S38. https://doi.org/10.1177%2F0194599819890327 http://www.ncbi.nlm.nih.gov/pubmed/31910111?tool=bestpractice.com
Oxygen supplementation, intravenous access, urgent complete blood count, platelets, clotting studies, and blood type for transfusion are required, along with the maintenance of airway, breathing, and circulation (ABC).
treatment of underlying cause
Treatment recommended for SOME patients in selected patient group
Coagulation disorders require management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
Treat local causes (e.g., neoplasm, foreign body, polyp, ulceration to the skin around the nose) accordingly.
Provide a post-treatment nosebleed instruction sheet.
quiescent but recurrent epistaxis
treatment of underlying cause
The patient may present with recurrent epistaxis that is not currently active.
Recurrent episodes may also occur in people with coagulation disorders, neoplasms, and familial hereditary hemorrhagic telangiectasia.
On occasion, the nasal septum is re-lined with a skin graft (septal dermoplasty).[19]Reibez EE, Bryan DJ, Ehrlichman RJ, et al. Surgical management of life threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg. 1995 Aug;35(2):208-13. http://www.ncbi.nlm.nih.gov/pubmed/7486747?tool=bestpractice.com [20]Lund VJ, Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasias. Am J Rhinol. 1999 Jul-Aug;13(4):319-22. http://www.ncbi.nlm.nih.gov/pubmed/10485021?tool=bestpractice.com [45]Zohar Y, Straus M. Epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope. 1995 Apr;105(4 Pt 1):445-6. http://www.ncbi.nlm.nih.gov/pubmed/7794350?tool=bestpractice.com
Coagulation disorders require management depending on the underlying cause.
Patients with hereditary hemorrhagic telangiectasia have a lifelong proclivity for bleeding from dilated, fragile mucosal vessels. Periodic prophylactic silver nitrate, electrocautery, or laser treatment may ablate vessels. Resurfacing of the septum (septal dermoplasty) may be an option.[19]Reibez EE, Bryan DJ, Ehrlichman RJ, et al. Surgical management of life threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg. 1995 Aug;35(2):208-13. http://www.ncbi.nlm.nih.gov/pubmed/7486747?tool=bestpractice.com [20]Lund VJ, Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasias. Am J Rhinol. 1999 Jul-Aug;13(4):319-22. http://www.ncbi.nlm.nih.gov/pubmed/10485021?tool=bestpractice.com [45]Zohar Y, Straus M. Epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope. 1995 Apr;105(4 Pt 1):445-6. http://www.ncbi.nlm.nih.gov/pubmed/7794350?tool=bestpractice.com
Neoplasms and trauma must be addressed according to the particular nature of the patient's disease. Preoperative embolization reduces blood loss in some cases: for example, juvenile nasal angiofibroma.[11]Davis KR. Embolization of epistaxis and juvenile nasopharyngeal angiofibromas. AJR Am J Roentgenol. 1987 Jan;148(1):209-18. http://www.ajronline.org/doi/pdf/10.2214/ajr.148.1.209 http://www.ncbi.nlm.nih.gov/pubmed/3024474?tool=bestpractice.com
Coagulopathy requires management depending on the underlying cause and may need to be corrected with transfusion of platelets, or clotting factors.
silver nitrate cautery
Treatment recommended for SOME patients in selected patient group
This is a common scenario in children.
Determine which side has the worst bleeding, as this would be the side selected for cautery. It is important to avoid cautery at the same location on both sides of the septum. This deprives the septal cartilage of its blood supply (from the mucosal covering) and may result in septal perforation if done bilaterally. Defer similar treatment of the other side for about 4 weeks until the initial cautery site has healed.
Younger children may not tolerate simple office cautery even with good topical anesthesia and thus require brief general anesthetic.
Silver nitrate cautery has been compared with antiseptic creams in children with recurrent epistaxis.[42]Qureishi A, Burton MJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004461. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004461.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22972071?tool=bestpractice.com [43]Loughran S, Spinou E, Clement E, et al. A prospective, single blind, randomised controlled trial of petroleum jelly/Vaseline for recurrent paediatric epistaxis. Clin Otolaryngol Allied Sci. 2004 Jun;29(3):266-9. http://www.ncbi.nlm.nih.gov/pubmed/15142073?tool=bestpractice.com One Cochrane review of interventions in children is inconclusive, but does suggest that if silver nitrate cautery is used, a 75% preparation may be more effective and less painful than 95%.[42]Qureishi A, Burton MJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004461. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004461.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22972071?tool=bestpractice.com Petroleum jelly has been compared with no treatment.[42]Qureishi A, Burton MJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004461. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004461.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22972071?tool=bestpractice.com The evidence for antiseptic creams and petroleum jelly is still limited and high quality randomized controlled trials with longer follow-up periods are required.[42]Qureishi A, Burton MJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004461. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004461.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/22972071?tool=bestpractice.com [43]Loughran S, Spinou E, Clement E, et al. A prospective, single blind, randomised controlled trial of petroleum jelly/Vaseline for recurrent paediatric epistaxis. Clin Otolaryngol Allied Sci. 2004 Jun;29(3):266-9. http://www.ncbi.nlm.nih.gov/pubmed/15142073?tool=bestpractice.com [46]Ruddy J, Proops DW, Pearman K, et al. Management of epistaxis in children. Int J Paediatr Otorhinolaryngol. 1991 Apr;21(2):139-42. http://www.ncbi.nlm.nih.gov/pubmed/1889950?tool=bestpractice.com A late double-blind study suggests that silver nitrate cautery plus antiseptic cream confers greater benefit than antiseptic cream alone.[44]Calder N, Kang S, Fraser L, et al. A double-blind randomized controlled trial of management of recurrent nosebleeds in children. Otolaryngol Head Neck Surg. 2009 May;140(5):670-4. http://www.ncbi.nlm.nih.gov/pubmed/19393409?tool=bestpractice.com
endoscopic management or angiography and embolization or open surgery
Treatment recommended for SOME patients in selected patient group
An ear, nose, and throat specialist assesses which of the options would best balance the risks and benefits for each individual patient.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer